Neurosense Therapeuti -CW23NRSNWPreferred / convertible
13F holders, Q1 2024 (March 31)4holders
1famous investor
$0.42avg. 13F price*
At the end of Q1 2024, 4 institutions reported holding Neurosense Therapeuti -CW23 (NRSNW) in their 13F filings. The largest holders were Hudson Bay Capital Management LP ($36K), Clear Street LLC ($25K) and Citadel Advisors ($20K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Neurosense Therapeuti -CW23
- CUSIP
- M74240116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $20K |
| Exits | 0 | $0 |
Ownership 4 holders
| Hudson Bay Capital Management LP | — | No change | 86,753 | $36K |
| Clear Street LLC | — | Reduce -0.2% | 59,172 | $25K |
| Citadel Advisors | — | New | 48,138 | $20K |
| Warberg Asset Management LLC | — | Reduce -34.8% | 41,406 | $17K |
"% of holder's portfolio" is NRSNW's weight in each manager's 13F, not the share of Neurosense Therapeuti -CW23 the manager owns.